Drug Approval
Drug Approval is a regulatory decision process within pharmaceutical governance that authorizes the commercialization of a medicinal product following demonstration of its safety, efficacy, and quality in accordance with established legal and scientific standards.
2.2K
Publications
98.2K
Citations
5.3K
Authors
1.9K
Institutions
Publications per year
2017–2026
747
Variants
Drug Marketing AuthorizationPharmaceutical Approval
2.2K
1–5 of 2.2K
5.3K
40
h-index
24
h-index
20
h-index
17
h-index
London School of Economics and Political Science, United Kingdom
15 publications · 800 citations
15
h-index
1–5 of 5.3K
1.9K

Brigham and Women's Hospital
Boston, United States
44 h-index
250 publications
15.4K citations
United States Food and Drug Administration
Silver Spring, United States
41 h-index
360 publications
18.6K citations
Harvard University
Cambridge, United States
40 h-index
217 publications
13.4K citations
Center for Drug Evaluation and Research
Silver Spring, United States
36 h-index
306 publications
16.1K citations
Yale University
New Haven, United States
26 h-index
100 publications
6.9K citations
Tufts University
Medford, United States
26 h-index
85 publications
4.4K citations
Utrecht University
Utrecht, The Netherlands
25 h-index
113 publications
4.5K citations
London School of Economics and Political Science
London, United Kingdom
23 h-index
68 publications
4.3K citations
1–8 of 1.9K
NEJM · 80 publications · 5.9K citations
42
h-index
Repository · 139 publications · 4.8K citations
37
h-index
CPT · 88 publications · 4K citations
34
h-index
34 publications · 3.1K citations
31
h-index
58 publications · 5.4K citations
28
h-index
1–5